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1. Introduction  
Adverse health effects of air pollution are well established mostly through epidemiological 
studies, although also toxicology is consistently accumulating findings as to the underlying 
mechanisms of these effects. Mostly, it seems, these mechanisms are not very specific: 
inflammatory processes and oxidative stress predominate. Some pollutants also have 
mutagenic properties making cancer also a plausible health endpoint of exposure to air 
pollution. But the long lags between exposure and final disease make epidemiological 
studies in this field very difficult, so direct epidemiological evidence for cancer effects of air 
pollution is rare. Nevertheless the few existing studies give a consistent and plausible 
picture. More importantly there are studies that rather than looking at ultimate disease 
investigate biological effects that might lead to cancer like DNA adducts or chromosome 
damage. So even for cancer epidemiological evidence is growing. 
Several reviews have described the health effects of air pollution in more detail, namely 
reports by the World Health Organization (WHO 2000; 2005; 2006; 2007) and by the Health 
Effects Institute (HEI 2000; 2003; 2007; 2010). This chapter will not repeat these valuable and 
extensive summaries but is rather interested in the link between the scientific findings and 
policy implications. In fact policies do not deal with air pollution per se, but with specific 
sources of air pollution thus affecting the interests of several influential stakeholders. So 
from a policy perspective science is not only called to estimate the health effect of ‘air 
pollution in general’ but the health effects linked to a specific source of air pollution or more 
precisely a specific incremental change in pollutants production by that specific source. 
Air pollution always consists of a whole range of pollutants, gaseous and particulate alike. 
Keeping in mind the little specificity of the air pollutants' toxicity it is not surprising that not 
one single pollutant alone accounts for the observed effects. Routine monitoring of air 
quality is usually restricted to some very few indicators (particulate mass and some gases 
like ozone, nitrogen oxides, sulphur oxide, and carbon monoxide). Simply because of data 
availability most epidemiological studies describe the association between those indicator 
pollutants and health risks. But that does not mean that other usually unmeasured 
pollutants (polycyclic aromatic hydrocarbons, volatile organic compounds, aldehydes, to 
name but a few) are not similarly relevant in terms of health effects. Particle mass itself is an 
indicator covering a whole range of particles differing in size, shape and chemical 
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composition. Although the routine indicators of air quality have been shown to be generally 
good indicators of the overall air quality it cannot be expected that their health relevance is 
the same no matter what their very source is: particles from incineration processes (e.g. 
exhaust pipes of motor cars or industrial stacks) are certainly different from particles 
stemming from desert storms or from sea salt spray.  
So policy is required not just to do some ‘indicator variable cosmetic’ but tackle those sources 
with the largest health relevance. Ideally it would not only be health effects of air pollutants 
that are mitigated by a successful policy. Take road traffic as an example: A successful policy 
would not only reduce air pollution but also noise, CO2 and risk of accidents. 
Thus source-specific effects of air pollution are one issue when science meets policy. Another 
equally challenging issue is the communication of scientific findings. Both health effects of air 
pollution and the costs of reducing air pollution are very emotional issues and science is not 
suited well to deal with emotions. Making things worse the talk is about ‘risk’ and the 
understanding of that word differs a lot between lay and scientific language. For a scientist ‘risk’ 
has a purely statistical meaning while a lay person is more interested in individual risk. In that 
case the term would include fear which is not so much associated with the statistical likelihood of 
an event but with (inter alia) its strangeness and severity. A ‘good story’ making an event more 
plausible in individual terms might make a risk more relevant while a perception of own control 
(even if misguided) will reduce the fear and thus the feeling of risk. 
Even more importantly epidemiologists tend to talk about relative risks, and small relative 
risks indeed in the case of air pollution: Since everybody is exposed to air pollution to some 
extent it is not possible to describe the risk of exposure relative to non-exposure, but usually 
the relative risk of an incremental increase of exposure is given. Considering reasonable 
increases in exposure (e.g. per 10 µg/m³ of fine particles, PM2.5) the incidence of some 
health effects might increase by a few percent or even less (depending on the averaging time 
of the exposure under study). For rare diseases increase in incidence (or prevalence) by a 
few percent is by no means much. An individual should not be deeply concerned about 
these additional risks, not only because these risks are small, but also because (s)he usually 
cannot do anything about it personally. So it might be seen as common logic that risks of 
that kind are usually disregarded by the general public. Nevertheless for the whole 
population even relatively rare diseases translate into a certain number of patients and any 
additional patient is an additional burden to society and the health care system, not to speak 
about individual hardships. These individual patients will never be proved to be caused by 
air pollution. The unspecific nature of the pollutants' effects makes it impossible to discern 
the individual causes. Nevertheless there are a number of additional cases of disease and 
death that could have been prevented but for the totally involuntary exposure to air 
pollution. Since practically everybody is exposed to air pollution also small relative risks 
translate into a surprisingly large number of additional ‘cases’. 
So science faces the task to explain small individual risks that still are relevant for society. 
Ideally this explanation should not end at ‘air pollution per se’ but should strive to discern 
different sources of air pollution. The latter is not only difficult because of the complex 
mixture of pollutants originating from each individual source but also because there is a 
long way from the pollution source to the population exposure where not only the chemical 
composition of the pollution mixture at the source must be considered but also chemical fate 
and distribution on its way to the noses of the people. This indeed calls for some 
interdisciplinary efforts. 
 
2. The concepts of causality 
Aristotle discerned four kinds of causes, where his term of "cause" (Greek aitia) had a 
broader meaning than today's "cause": Thus "causa materialis" and "causa formalis" describe a 
thing (by its material substance and its form) while the latter two "causes" are more in line 
with the modern meaning. It seems noteworthy that only the "causa efficiens" resembles the 
modern concept of a cause preceding the effect ("poster hoc ergo propter hoc") while the 
concept of "causa finalis" is usually not used in natural sciences. Nevertheless in social 
sciences it is well established that also goals (i.e. intended future events) strongly influence 
current events. Life sciences are positioned in the grey zone between natural and social 
sciences. Therefore it is not surprising that biological mechanisms could be described either 
by the concept of "causa efficiens" or of "causa finalis". While it is just and common belief that 
each process in life has at least one preceding cause because of the complexity of most causal 
chains and networks it is often more straightforward and easier to understand and 
memorise mechanisms that are described in relation to their intended goal. For example 
inflammation could be explained by describing all the cytokines and mediating substances 
involved or it could be described as a mechanism shaped to clean the organism from 
unwanted material like microbes or noxious chemicals. The latter explanation makes it 
easier to understand the importance but also the possible harmful effects of such a process. 
Often this is more relevant for an understanding that can inform reasonable intervention. 
Nevertheless in this paper "cause" is understood in its natural science meaning. 
In formal logics simple causal chains can be constructed like "A causes B, B causes C, etc." 
but in real world settings causality is often more complex like "A, B, and C cause D which in 
turn causes E and F and prevents G and H which again in turn exact an influence on A, B or 
C". Thus we might have complex positive or negative feedback loops and often we even 
have no means to know or monitor the true underlying causes of an event but are restricted 
to proxy data that are only somehow related to or associated with the truly causal factor. In 
theory natural scientists formulate hypotheses that can be falsified. But at least in the 
complex world of life sciences neither "proof" nor falsification are easy tasks. More often 
collected data only can render hypotheses more or less plausible. As a consequence 
"causality" in life sciences tends to be a fuzzier term than in physics. 
In their very enlightening book Rifkin & Bouwer (2008) propose the "Risk Characterisation 
Theatre" to illustrate risks. "If there were 1,000 people sitting in a theatre with significantly 
elevated cholesterol levels of 280 mg, there will be one additional death per year from 
coronary heart disease as compared to 1,000 people with normal cholesterol." Even more 
impressive is their example concerning benefits of colorectal cancer screening: "If there were 
1,000 people sitting in a theatre who had colorectal cancer screening, there will be one cancer 
prevented over a life time as compared to 1,000 people not screened." This statement is 
striking considering modern theatre: were people seated there over a life time they would 
rather die of boredom than of colon cancer. 
Apart from these entertaining examples clearly indicating that absolute risks are more 
relevant and meaningful to us than relative risks the authors also introduce a second term in 
addition to "cause". In chapter two they set out to explain the differences between "cause 
and effect" versus "risk factors" but in my mind they completely fail to succeed. Their first 
example for a "risk factor" is a "lump in the breast detected in a mammogram". This they 
declare to be a "risk factor" (and evidently not a cause) for breast cancer. "There is no cause 
and effect relationship because the presence of a lump is not always associated with cancer." 
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Now this is interesting! Following this line of argumentation smoking would not be causally 
linked with lung cancer because it does not always lead to that outcome. Or even shooting a 
person would not be causally linked to his or her death because a bullet not always leads to 
it. While I agree that a "lump in the breast" is not the cause of breast cancer (rather the other 
way round!) I also do not consider a lump as a risk factor, only as a symptom! In fact the 
authors are not very clear regarding their distinction between "cause" and "risk factor". 
Maybe they just have the feeling that a "cause" is a rather strong risk factor. But since they 
question the validity of relative risks and do not give a threshold in terms of absolute risks 
to discern between "cause" and "risk factor" their terminology remains obscure. Sometimes it 
seems they understand by "cause" an event that practically always leads to an effect but 
even for the examples they give this is usually not the case. Alternatively they might mean 
by "cause" an event that practically always precedes an effect. The typical example would be 
infectious diseases: Tuberculosis is always caused by mycobacteria. But in fact this 
statement is rather a tautology because tuberculosis is defined as being caused by 
mycobyacteria. Tuberculosis can take many forms from acute to chronic pneumonia, 
inflammation of practically every body part, silent knot or scar in the lung tissue, caverns in 
the lung or septicaemic disease. Often only when we detect mycobacteria (or at least an 
immune response against these bacteria) do we diagnose tuberculosis. Pneumonia is not 
always caused by mycobacteria and mycobacteria not always cause pneumonia. In fact 
many people have been exposed to mycobacteria and only few of them have developed any 
kind of disease at all.  
The so-called Koch's postulates2 that were first proposed by Henle and then by Koch (1884) 
but coined as a term by Koch's pupil Loeffler are often seen as criteria of causality (Evans, 
1976) and even are revoked with new emerging concepts of infectious disease (Walker et al., 
2006; Falkow, 1988). But even Koch himself was aware that these were rather a description 
of the microbiology methods of his times and no criteria of causation. The misconception of 
the postulates stipulating causation indeed hindered for some time the wide acceptance of 
viruses as infectious agents. 
Looking at the postulates without prejudice rather provokes the idea that microbiology 
lacks good proofs of causality at least regarding individual cases. The only fact the 
postulates help to establish is the ability, not the necessity of any bacterial strain to cause a 
certain disease. 
 
Unfortunately with environmental epidemiology the situation is not much better (Kundi, 
2006). Here the so-called "Bradford-Hill criteria”3 are widely supposed to indicate causation. 
                                                                 
2 Koch's postulates are: 
 1. The microorganism must be found in abundance in all organisms suffering from the disease, but 
should not be found in healthy animals. 
 2. The microorganism must be isolated from a diseased organism and grown in pure culture. 
 3. The cultured microorganism should cause disease when introduced into a healthy organism. 
 4. The microorganism must be reisolated from the inoculated, diseased experimental host and 
identified as being identical to the original specific causative agent. 
3 Hill's criteria are: 
 1. Strength: A small association does not mean that there is not a causal effect. 
 2. Consistency: Consistent findings observed by different persons in different places with different 
samples strengthen the likelihood of an effect. 
 
Just by calling them "criteria” makes them seem like a "check-list” (Phillips and Goodman, 
2004), but this was not Bradford Hill's intention. In his seminal presentation (1965) he 
explicitly stated: "None of my nine viewpoints can bring indisputable evidence for or 
against the cause-and-effect hypothesis and none can be required sine qua non". 
Comparing infectious with "environmental” diseases (like those caused by air pollution) is 
not so far fetched. In fact it is known that only rarely a single bacterium causes a disease. 
This lead to postulating the "infectious dose”, the minimal amount of bacteria that are 
necessary to trigger a disease. But microbiologists soon discovered that this is not so easy: 
apart from "factors of virulence” of the bacteria there are also susceptibility factors of the 
host. Indeed it was shown that co-exposure of bacteria and air pollutants increase the 
likelihood of an infectious disease: the damaged mucous membranes of the airways are 
more susceptible to the attack of germs. So what causes the disease? Most people would 
answer: "the germ, because we always find germs when there is an infection!” I could easily 
respond: "I checked it and I always found air pollution!”  
I do not believe that finding germs establishes their causal role. What indeed does is 
therapeutic success: We are willing to accept those factors as "causal” which we can 
successfully influence. When I sit in a tram and a person besides me coughs or sneezes I 
automatically try to hold my breath until the germ bearing plume has settled. When I walk 
on the kerbside and a lorry passes by I try to do the same. Asthmatics could react to health 
warnings on high pollution days (Wen et al, 2009). Here the similarities between (chemical) 
air pollutants and infectious agents end: I have no antibiotics, no vaccination, no quarantine 
measures to offer to fight health effects of air pollution. It has been shown that good 
pharmacotherapy of asthma also mitigates exacerbations caused by air pollution (Song et al., 
2009; Gilliland et al., 2009; Qian et al., 2009a; Trenga et al., 2006. But see also Quian et al., 
2009b). But this is not a therapy against air pollution – it is simply good asthma therapy. 
The individual doctor with her individual patient will not tackle air pollution, hence air 
pollution is outside her scope. But as a society we can really do something about air 
pollution while we are not very successful in fighting infectious agents: We have until now 
only conquered smallpox and polio might follow soon. In the meantime a whole bunch of 
new deadly viruses has been detected. Everywhere where people meet or come in contact 
with animals or even besides that, there is a risk of infection. Contrary to that our western 
civilisation was fairly successful in reducing air pollution. Indeed it was not until pollution 
levels were considerably reduced that epidemiologists were able to show that even low 
levels previously considered "safe” had in fact still an adverse effect on health. 
                                                                                                                                                                   
 3. Specificity: Causation is likely if a very specific population at a specific site and disease with no 
other likely explanation. The more specific an association between a factor and an effect is, the 
bigger the probability of a causal relationship. 
 4. Temporality: The effect has to occur after the cause (and if there is an expected delay between the 
cause and expected effect, then the effect must occur after that delay). 
 5. Biological gradient: Greater exposure should generally lead to greater incidence of the effect. 
However, in some cases, the mere presence of the factor can trigger the effect. 
 6. Plausibility: A plausible mechanism between cause and effect is helpful. 
 7. Coherence: Coherence between epidemiological and laboratory findings increases the likelihood 
of an effect.  
 8. Experimental evidence. 
 9. Analogy: The effect of similar factors may be considered. 
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I therefore hold that as a society we should more seriously consider air pollution as cause of 
disease. But health-policy makers usually fail to make health-policy but rather engage in 
disease management. Their experts usually are learned doctors (if policy-makers do indeed 
ask experts) who know how to treat individual disease or have studied the economy of the 
healthcare system. "Environment” is usually out of the scope of both. 
 
3. The proof of the pudding 
“The proof of the pudding is in the eating”, is an old proverb. The most suggestive proof of 
the causal effects of air pollution on health is the beneficial effect of air pollution reduction 
(Renzetti et al., 2009). Be it the unintended side effect of a year long strike at a steel plant 
(Ghio & Delvin, 2001; Dye J et al., 2001; Pope et al., 1989) or of the short term improvements 
in air pollution due to a special transport scheme with restrictions of private cars during the 
Olympic Games in Atlanta (Friedman et al., 2001) or in Beijing (Wu et al., 2010) or during 
the 2002 summer Asian games in Busan (Lee et al., 2007). Even more impressive are the 
effects of specific measures with a lasting impact like the ban of coal sales in Dublin (Clancy 
et al., 2002) or in other Irish towns (Rich et al., 2009). The same holds true for the reduction 
of sulphur in fuels in Hong Kong (Hedley et al., 2002). 
It is more difficult to show the benefit of gradually improving air quality that was seen over 
the last decades in many developed countries due to continuous technology improvements. 
A single measure that induces a significant improvement of air quality at once leads to a 
reduction in daily deaths. But fewer deaths in the short run will just make the age 
distribution of the population shift thus increasing that part of the population with the 
highest risk of dying. So in the long run daily death counts will not change: Everybody is 
bound to die exactly once. Therefore with gradually improving air quality no telling 
changes in daily mortality will be seen. We expect an increase in average life expectancy 
which indeed is the case in many countries. But two parallel trends like those of air quality 
and life expectancy are no proof of causal association. Indeed there are likely many causes of 
the increasing life expectancy and air quality is maybe not its most important cause.  
It is reasonable to assume that death from air pollution will not affect all people equally. 
There are bound to be susceptibility factors like diabetes (Jacobs et al., 2010) but many are 
only partly understood by now and even include socio-economic factors (Barcelo et al., 
2009). Improvements in air quality will therefore at the foremost increase the life expectancy 
of that group of people who are most susceptible towards air pollution. So we might expect 
that this group will increase in number relative to the whole population. In that case we 
would expect a steeper dose-response slope for air pollution and mortality with overall 
improving air quality. Indeed Shin et al. (2008) clearly showed this trend for Canada and 
nitrogen dioxide (NO2) although they failed to interpret their finding as an indication of a 
beneficial effect of reduced NO2 levels. 
 
4. Relative risks 
Relative risks get increasingly criticised (Poole, 2010; Kaufman, 2010). But a high relative 
risk certainly is convincing. Consider a very rare disease, say, that occurs in one person only 
in every 100,000. Your doctor might not have seen this disease once and certainly not more 
often in her whole professional life. Then consider a group of people, say 500 workers in a 
 
special industrial plant, and of these five develop this disease: one in hundred, or a relative 
risk of 1000:1 (1:100/1:100,000)! That does tell us something, doesn't it? There must be an 
exposure in this plant that poses a very strong risk factor. This is really bad news for the 500 
employees. But still for them it does not mean certain doom, only a one in hundred risk. 
Now consider a frequent disease like arteriosclerosis. One in three might develop it. And 
consider an agent we are all to a higher or lesser degree exposed to, like air pollution and 
the relative risk is negligible! Maybe RR is 1.01 (a one percent increase) or even less. No 
doctor will realise when she suddenly has one percent more patients with this diagnosis 
among her clients: She might have seen 10 of them each day. Now she sees one more every 
tenth day. Yet in each population of 1000 you would have approximately 3 additional cases, 
and we are not talking about small groups of 1000 people only but about all citizens of your 
country! So with this tiny relative risk we end up with many more affected people than with 
the huge risk and the 5 workers at the one industrial plant. 
Frequent diseases usually are frequent because they do have multiple causes. So each cause 
will only contribute a small percentage to the disease. This makes recognising the cause a 
difficult task. But if the cause is widespread it still can mean a relevant number of additional 
diseases. This exactly is the case with air pollution. 
 
5. Duration of exposure 
We are always exposed to air and the air is never free of pollutants. Hence we are always 
exposed to air pollution. Nevertheless it might be different if we are exposed to an episode 
of very high pollution for a rather short time or if we are exposed to a lower concentration 
for a longer period (even so that the dose, which is the concentration multiplied by time, is 
the same). Analysing short or long term exposures calls for different study concepts. 
For short exposures and acute effects two concepts are broadly used. The first is the panel 
study: you select a group of volunteers that, as they live on, are exposed to ever changing 
concentrations of air pollutants that you are somehow able to monitor. These volunteers 
undergo repeated medical check-ups like lung function testing or analysis of inflammatory 
or cardiovascular markers. By analysing your data you can investigate the effect of short 
term changes of air pollution on the selected health parameters. This approach allows you a 
deeper insight in the influences of biological mechanisms even before the outbreak of overt 
disease. But when you are interested in disease outcome you must keep in mind the small 
relative risks you might expect. Therefore you need large numbers of people and long 
observation periods for meaningful statistics. This is the realm of time series studies: These 
can rely mostly on public data. A person that has diabetes today will likely have diabetes 
tomorrow. She who smokes today will likely be a smoker tomorrow. He who lives in a poor 
crowded area today will usually do so tomorrow. All these individual factors therefore will 
not confound the effects of day-to-day variation in air pollution. Therefore you can use 
public data like daily mortality rate or hospital admissions as a health outcome. Also daily 
air pollution is available from urban monitoring networks. Only factors that also change on 
a temporal scale can confound the association and must be taken into account: season, 
weather, influenza epidemics, holidays and weekends. Weather and season are very likely 
confounders because they both affect health and air pollution levels, but they can easily be 
controlled for. On weekends consistently fewer deaths are reported. This might partly be a 
spurious finding when deaths on Sunday are only discovered and/or reported on Monday. 
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But certainly there is also a true beneficial weekend effect. This is noteworthy because 
contrary to weather and season the weekend is not a natural phenomenon but a purely 
societal construct: It is the very way we organise our society that has a measurable effect on 
health! Maybe this information is already relevant for health policy: It does not matter so 
much if the final mechanism that makes workdays more dangerous is via societal stress, via 
noise, via air pollution (which is indeed lower on weekends), or via any other unknown 
route. It might be scientifically rewarding to disentangle the very contribution of air 
pollution. But for policy it is already important to know that "something” is wrong with the 
way we design our working days. 
A typical outcome of time series studies on air pollution and mortality is "additional deaths 
per day per a certain change in air pollution concentration”. For 10 µg/m³ of fine particles 
(PM2.5) this is in the magnitude of approximately 1%. Cohort studies, that analyse the impact 
of long term air pollution exposure, produce a different outcome. To study long term exposure 
you cannot rely on day-to-day changes in air pollution but you must compare the health and 
fate of people that are continuously exposed to different levels of air pollution on average. A 
sensible choice would be to compare inhabitants of two (or more) cities with different average 
air pollution. The inhabitants of each city with certain characteristics (e.g. you could select 
people according to age group) are seen as a “cohort” (hence the name of the study concept), 
i.e. a group of people defined by common characteristics and an exposure level. Your interest 
lies in the fate of each cohort: do they differ in disease or mortality risk? So in mortality studies 
your outcome would not be (daily) counts of deaths but percentages of deaths per age-group 
and year, i.e. annual rates instead of daily counts. With the help of population tables you could 
easily translate differences of rates into differences of average life expectancy. This you cannot 
do with daily counts, because you do not know if a death prevented today leads to only a few 
additional days or to many more years of life. 
Cohort studies are much more demanding than are time series analyses: When comparing 
different groups (cohorts) of people every characteristic that differs between the cohorts 
might confound the effects. So you must strive to collect as many data that are relevant to 
life expectancy as possible about all members of each cohort. These include age and sex, 
smoking behaviour, pre-existing disease status, job categories, educational and socio-
economic status, and many others. And still you cannot be sure that you have covered all 
possible confounding factors. 
This is why cohort studies are rarer than time series. Nevertheless they find stronger effects: 
With time series a 10 µg/m³ change of PM2.5 led to an approximately 1 % change in risk, 
with cohort studies this would typically be around 10%. So it is encouraging to see that 
when you do time series studies and you look at increasingly longer exposure periods, e.g. 
look at the effects of same or previous day pollutants, then at effects of average pollution 
over the previous 2, 3, 4 days or 1 to 4 weeks you will usually find that the longer the 
averaging period the stronger the effect. This does lend additional support to the stronger 
findings of cohort studies. 
The general concept states that one must be seriously ill to acutely die from an air pollution 
episode. But long exposure causes additional disease thus increasing the number of people 
at a high risk of death. Mechanisms of disease generation involve inflammatory processes 
(Jacobs et al., 2010; Flamant-Hulin et al., 2010; Thompson et al., 2010; Strak et al., 2010; 
Hildebrandt et al., 2009; Panasevich et al., 2009; Hoffmann et al., 2009), oxidative stress 
(Kang et al., 2010; Sawyer et al., 2010), mutagenicity of some air pollutants, and autonomic 
regulation of the cardiovascular system (Franchini & Mannucci, 2009). 
6. Source specific effects 
Linking pollutants' effects to certain sources has been done by source apportionment (Sarnat 
et al., 2008; Watson et al., 2008; Andersen et al., 2007; Ilacqua et al., 2007; Kim & Hopke, 
2007; Grahame & Hidy, 2007; Chen et al., 2007; Brook et al., 2007; Zheng et al., 2007) through 
chemical tracers (Moreno et al., 2009; Patel et al., 2009, Delfino et al., 2009; Lin et al., 2010; 
Kleeman et al; 2009; Hwang et al.; 2008; John et al., 2007; Seagrave et al., 2006; Grahame & 
Hidy, 2004) or GIS methods (Vienneau et al., 2009; Aguilera et al., 2009), making use of 
dispersion models (Jacquemin et al., 2009; Kostrzewa et al., 2009), land use regression 
techniques (Karr et al., 2009; Su et al., 2009), Bayesian structural equation models (Nikolovet 
al., 2007) or principal components analysis (McNabola et al., 2009; Sanchez et al., 2008).  
Not all approaches are equally convincing. Morgan et al. (2010) set out to study the effect of 
bushfire smoke in Sydney, Australia. In this town fine particle concentrations (PM10) are 
usually low and only high on bushfire days. So they performed two different time series on 
daily mortality: one on high pollution days, and one on “normal” days. They found that the 
per 10 µg/m³ increase in daily deaths was stronger during “normal days” and concluded 
that PM10 from bushfire is less harmful than the usual urban PM mix. But the not so steep 
slope at higher concentrations could well be due to a saturation effect that leads to a non-
linear dose response curve and has nothing to do with the source of the pollutants. 
Many different sources of air pollution have been investigated as causes of adverse health 
effects. These include, among others, municipal waste incinerators (Goria et al, 2009), 
residential heating (Junninen et al., 2009) and especially wood smoke (Karr et al., 2009; 
Naeher et al., 2007), local point sources (Karr et al., 2009) and even desert sand (Perez et al., 
2008; Sandstrom & Forsberg, 2008; Shinn et al., 2003). But more than any other sources road 
transport has been linked to adverse health effects (Adar and Kaufman, 2007; Fan et al., 
2009; Brunekreef et al., 2009; Rosenlund et al., 2009; Migliore et al., 2009; Hart et al., 2009; 
Delfino et al., 2009; Aguilera et al., 2009; Perez et al., 2009a; Perez et al., 2009b; Kramer et al., 
2009; Kunzli et al., 2009; Tonne et al., 2009; Ranft et al., 2009; Pedersen et al., 2009; Ryan et 
al., 2009; Eisner et al., 2009; Gent et al., 2009; Ho et al., 2010). Only few studies (e.g. Pujades-
Rodriguez et al., 2009) could not confirm this association. In these and many more studies 
exposure to road transport has been estimated by considering current home or school 
address or a history of past home addresses. For these addresses exposure was assessed 
using proxies like distance to next busy road, number of vehicles per day on the road next to 
the home, or a combination of both, or more advanced models also taking wind direction 
etc. into account. Various health endpoints were investigated. Therefore in spite of the 
impressive list of studies even for road traffic derived air pollution some more research is 
needed before firm conclusions as to the underlying sources and effects can be drawn and 
reliable dose-effect relations can be described. Regarding the sources it still is not clear 
which exhaust-pipe emissions are the main culprits nor to what extent other transport-
related emissions including noise and mechanically generated particles like tire or break 
wear or re-suspended road dust contribute to the various effects. This makes it difficult to 
estimate the relative impact of any specific technical measure like a filter or an innovative 
propulsion technique. What can be recommended clearly and without hesitation is to 
generally reduce road traffic in inhabited (urban) areas and/or not to place sensitive 
exposure groups (like children through kindergartens or schools) near busy roads. 
The knowledge base is much less advanced for other sources of air pollution where there are 
only few studies for each specific source and exposure situation often varies fundamentally 
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according to specific local circumstances like meteorological conditions or the exact technical 
specification of the very source: not one power plant or one waste incinerator is exactly the 
same as the others. 
 
7. The phrasing of the message 
Telling policy makers and the public what to do is not easy for many reasons. First of all 
scientists do not want to tell others “what to do” but their first goal is to get additional funds 
to carry on their interesting research. Secondly, policy makers, media people, and the 
general public do not want to hear what scientists have to tell but what fits their current 
interests. Third, as we have seen above, there is still not a clear-cut message regarding 
specific sources and measures: Evidence based measures are bound to be based on a cost-
benefit analysis. But as long as the benefits cannot be quantified for lack of source and 
measure specific dose-response functions we are still a far way off the mark. 
Fourth, when it comes to cost-benefit statements, these are outside the narrow scope of 
environmental health science. Comparing benefits and costs intrinsically necessitates the 
monetary valuation of health benefits. But deciding on the value of reduced health risks is 
the task of society, not of scientists. Scientists are burdened with the task of explaining the 
magnitude of the risks (even including the uncertainties linked to this magnitude estimate) 
in an understandable, meaningful and correct way. 
The European Public Health Project “Aphekom” (http://www.aphekom.org) set out to 
(among other things) clarify the public's information needs: “What would be the best metric 
to explain the health impact of air pollution?” was just one of the questions a panel of air 
pollution scientists were asked at the Aphekom symposium during the ISEE conference in 
Dublin (Medina et al., 2009). Death is the most emotional outcome of air pollution. So not 
surprisingly much of the discussion centred on the question how changes in mortality risk 
were best described. There is a long ongoing debate whether “number of deaths” or 
“changes on life expectancy” or even “disability adjusted life expectancy” would be the 
better metric (Brunekreef and Hoek, 2000).  
At that workshop Bert Brunekreef again explained his position: “It is methodologically more 
correct to express the effects in the terms of disability adjusted life years and life expectancy rather 
than numbers of deaths or numbers of cases. But still we tend to think that the media and the public 
want to hear the numbers rather than the years of life lost. 
But when I teach about these issues I use to start my presentation with a very simple question to the 
audience: What matters more to you, what you’re going to die from eventually or how many years 
you’re going to live in reasonably good health? And no audience so far said that they want to know 
what they are going to die from, they are much more interested in how long they’re going to live in a 
reasonably good health.” 
Christophe Declercq mostly agreed with that position: “At the population level, the number of 
attributable cases by year is only an approximation. If the level of particulate matter decreases, age-
specific mortality rates of the exposed population will decrease. In the long term, the age structure 
will change as people will live longer. This will cause the mortality rates and the number of deaths by 
year to increase again. Therefore, from a theoretical point of view, the gain in life expectancy is a 
better metric than the number of attributable cases. This is true in the long term, fifty years or so, but 
for the next years to come, attributable cases can still be a useful approximation if it is simpler to 
communicate.” 
 
Joel Schwartz strongly disagreed with the position that “years of life lost” is better than 
“number of deaths”: “First of all, individual people would like to know how long they’re going to 
live but we can’t tell them that at all. We can tell them that an intervention that lowers air pollution 
changes average life expectancy but might not change theirs or might change it a lot more than 
average, so that’s not anything that we can tell them. What can we tell them, what is the product that 
we’re offering to sell them if society diverts some resources into pollution prevention? We can tell 
them that their risk goes down and there is a large and extensive literature on how people value 
reductions to risk. And that literature is uniformly reporting that years of life lost is not the metric 
that people value! The evidence of that is as strong as the evidence that cigarettes smoking causes 
lung cancer: 
If years of life lost were the metric which people value reductions in risk then one would expect a 
roughly linear decline in the bid with the age of the participants because 80 year-olds are not going to 
increase their life expectancy by nearly as much as 40 year-olds by this constant 1 in 10,000 
reduction in risk each year. And so that’s an empirically testable hypothesis and there was absolutely 
no association between what people were willing to pay and their age, in none of several studies done 
in the US, in Canada, in the UK.” 
Now I neither know what I would pay to get a certain percentage risk reduction nor what I 
would be willing to do for an additional year of life. I can understand “ten additional 
deaths” in a month or in a year in a certain population. I do not understand what a 
reduction in life expectancy by a few weeks or months means: Even if it were my personal 
life expectancy: I'd not so much want to know how much longer or shorter I live, but what 
will be the exact duration. Reducing my life expectancy by 3 weeks could mean I have to die 
tomorrow or in 40 years. So it is no meaningful information for me! Likewise it is not 
surprising that media and the public love “the numbers”. In the same workshop Marco 
Martuzzi gave an example that even the “wrong” numbers are nearly as good: “We estimated 
the deaths attributed to air pollution for the main Italian cities and came up with unusually large 
numbers which activated some debate. This was quite influential at the national level and mobilized a 
number of people. 
However some time later we were also invited by one of the cities. They had a heated debate regarding 
stricter measures for air pollution control and there was a tense situation with citizens and NGOs on 
one side and the local authorities on the other and we were asked to go there and present and discuss 
our study results. We arrived there and the situation was indeed quite tense and on the day of the 
event there had been headlines on the local papers saying: 50 deaths per year attributable to air 
pollution! In the heated discussion some said this is totally intolerable while others argued that 
compared to smoking this would be a very small and absolutely acceptable impact. After a while we 
were able to speak and to point out that they had got it wrong: it was 500, not 50 deaths per year! 
There was a moment of void but in the end nothing changed! The debate went on exactly the same!” 
So if the numbers really seem to be meaningless it is no wonder that Christophe Declercq 
argued for new aspects in communication: “I see the problem in the translation from the 
population level to the individual level. When you talk to the press or to the general public, and 
mention a number of attributable deaths, they will ask who are the victims. But we cannot answer to 
this question yet. But this question is not a bad question though. We know that there are inequalities 
in exposure to air pollution, which is higher for example in people living in proximity to the traffic, 
Some studies also suggest inequalities in the health effects of air pollution, and that this differential 
vulnerability is linked to the social status of the exposed population. So air pollution exposure and 
effects contribute to social inequalities in health. We need more research in this area, but what we 
already know should urge us to go beyond a summary indicator of health impact of air pollution, be it 
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according to specific local circumstances like meteorological conditions or the exact technical 
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number of attributable cases or life expectancy. If we want to assess benefits of air pollution public 
policies, we should also check that the more exposed and the more vulnerable part of the population 
gets larger benefits in terms of air quality and health.” 
Also Nino Künzli, who was one of the first to embark on the health impact assessment of air 
pollution (Künzli et al., 2000), warned against a too narrow look at mortality effects. But first 
he looked back to his seminal paper: “The derivation and the communication of risks based on 
epidemiological research has a long tradition and if we take the example of smoking it has not even 
been much debated how we do that and how we communicate that. Such billboards are shown all over 
the world to communicate to people how many deaths are attributable to smoking. These numbers are 
simply estimates of attributable risks taking the association between smoking and death and the 
prevalence of smoking into account. 
Some 10 years ago we applied these methods to answer a hot question asked by the ministers of health 
and environment of France, Austria and Switzerland: what is the health impact and what are the 
costs that can be attributed to ambient air pollution? 
While I do not consider this my most important paper it became indeed the most cited one of all I 
wrote so far. And why that? Because of the numbers of attributable deaths, we estimated 40,000 
attributable deaths per year due to air pollution. These numbers more than any other result in this 
same paper kept the world media quite busy and interested for years.” 
After also discussing “years of life lost” (the more accurate metric) and “number of deaths” 
(the more intuitive metric) he went on with – what he called – a provocative statement: “No 
matter what we use – either attributable deaths or years of life lost – we mislead and we distract from 
the relevant issues. Why that? 
Let me explain this with the lifetime model of the development of chronic states, of chronic diseases 
which of course increase with age. Mortality – be it expressed as numbers or years – comes only at the 
very end after the development of all these chronic pathologies. The state of health however is what 
matters. It is the timing of this lifetime period that matters. It is health that matters and it is health or 
the reduced health that ultimately determines our life time and our life expectancy. 
We are exposed over life time and this exposure entertains the development of chronic pathologies 
leading to lots of morbidities during life time and ultimately to premature death. We should invest far 
more in communicating that part of the air pollution related adverse effects. 
However, to focus the risk assessment on morbidity requires an expansion of our methodologies and 
an in-depth discussion with economists as well who continue to attach far higher monetary value to 
death. Also we all know that part of this money is virtual and we know that the morbidity is far less 
and less completely monetized and monetization is even based on different methodologies. So we 
should emphasize what happens during life prior to death but how should we do this in the risk 
assessment framework?” 
Nino Künzli went on to discuss the combined impact of long-term and acute exposure 
towards air pollution: chronic exposure is known to enhance or even cause arteriosclerosis 
(Hoffmann et al., 2007; Künzli et al., 2005; Sun et al., 2005). And if arteriosclerosis of the 
coronary arteries is present acute exposures can trigger myocardial infarction (Peters et al., 
2001). Similar phenomena are observed with respiratory disease: Chronic and especially 
early life exposure increases the prevalence of asthma (McConnell et al., 2006). And 
asthmatics react to acute air pollution episodes with more and more severe asthma attacks. 
It is still a challenge to present this combined effect of chronic and acute exposures in health 
impact assessments (Künzli et al., 2008). This in fact is the job of Nino Künzli's work-
package in the project Aphekom. 
 
The symposium in Dublin clearly showed the interest of the ongoing work on this issue in 
the Aphekom project which focuses on the need to improve the communication efforts and 
to fine-tune the relevant messages for the needs of the various stakeholders. 
 
8. Conclusion 
Adverse health effects of air pollution are well established. Experimental toxicological 
studies have shed light on relevant mechanisms and epidemiological data inform on the 
population relevance and the magnitude of the effects under realistic exposure scenarios. 
More recent research set out to define susceptible population subgroups. This will allow 
answering the question “who are the victims?” This question is of high policy relevance, but 
even more important is the question who the culprits are. Regarding sources there is ample 
evidence that proximity to road traffic poses serious health risks but other sources of air 
pollution including natural and industrial sources are likely equally dangerous as the 
average air pollution mixture on a mass concentration basis of currently used pollutants 
indicators (NO2, PM2.5). 
Research is ongoing to better define the impact of specific pollution sources and to better 
understand the effects of the whole pollution mixture as compared to a “pollutant-by-
pollutant” approach (Dominici et al., 2010). This is already reflected by a shift also in the 
policy frameworks (Greenbaum & Shaikh, 2010). Nevertheless there is still a far way to go. 
But gaps in current knowledge should not serve as an excuse for non-action: Where 
measures to improve air quality are feasible public health advantages are so striking that 
any cost-benefit analysis even in the light of uncertainty clearly proves that action is 
superior to non-action. So acting is not a question of uncertainty of benefits. In-action is 
caused by the difficulties in understanding health impacts and assessing these in relation to 
other interests that might not be as pressing, but easier to understand. Also the pressure of 
strong interest groups is often more successful than health concerns. 
Knowledge about culprits and victims empowers science to inform policy. But 
communicating small relative risks that render individual preventive measures less effective 
but still are relevant for the whole population is still a demanding task. The public wants 
and deserves clear and easily understandable answers. The reality might just be a trifle too 
complicated for that. 
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